Free Trial

Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics logo
$1.56 -0.02 (-0.96%)
As of 11:18 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BJDX vs. NURO, CODX, LFWD, TNON, SINT, POAI, LUCY, STRR, ICU, and STSS

Should you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include NeuroMetrix (NURO), Co-Diagnostics (CODX), Lifeward (LFWD), Tenon Medical (TNON), Sintx Technologies (SINT), Predictive Oncology (POAI), Innovative Eyewear (LUCY), Star Equity (STRR), SeaStar Medical (ICU), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

Bluejay Diagnostics vs. Its Competitors

NeuroMetrix (NASDAQ:NURO) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

Bluejay Diagnostics has a net margin of 0.00% compared to NeuroMetrix's net margin of -203.71%. NeuroMetrix's return on equity of -42.56% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroMetrix-203.71% -42.56% -39.26%
Bluejay Diagnostics N/A -322.46%-262.96%

NeuroMetrix has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.

In the previous week, Bluejay Diagnostics had 1 more articles in the media than NeuroMetrix. MarketBeat recorded 1 mentions for Bluejay Diagnostics and 0 mentions for NeuroMetrix. NeuroMetrix's average media sentiment score of 0.00 equaled Bluejay Diagnostics'average media sentiment score.

Company Overall Sentiment
NeuroMetrix Neutral
Bluejay Diagnostics Neutral

19.4% of NeuroMetrix shares are owned by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are owned by institutional investors. 7.3% of NeuroMetrix shares are owned by insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

NeuroMetrix has higher revenue and earnings than Bluejay Diagnostics. NeuroMetrix is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroMetrix$3.03M3.09-$6.53M-$4.59-0.99
Bluejay Diagnostics$250K9.27-$7.72M-$379.740.00

Summary

NeuroMetrix beats Bluejay Diagnostics on 8 of the 12 factors compared between the two stocks.

Get Bluejay Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BJDX vs. The Competition

MetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.32M$6.58B$5.51B$9.47B
Dividend YieldN/A1.33%4.00%4.04%
P/E Ratio0.0025.6128.1819.90
Price / Sales9.2768.98426.8892.15
Price / CashN/A20.4724.9928.17
Price / Book0.154.658.275.77
Net Income-$7.72M$176.14M$3.24B$257.79M
7 Day Performance-3.42%0.90%1.80%2.77%
1 Month Performance-0.32%4.36%9.32%14.17%
1 Year Performance-95.04%6.31%35.12%20.71%

Bluejay Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BJDX
Bluejay Diagnostics
0.4836 of 5 stars
$1.56
-1.0%
N/A-95.0%$2.32M$250K0.009Gap Up
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+19.8%$9.37M$3.03M-0.9920High Trading Volume
CODX
Co-Diagnostics
3.7735 of 5 stars
$0.27
+6.1%
$5.50
+1,973.9%
-78.0%$8.90M$3.91M-0.23100Positive News
High Trading Volume
LFWD
Lifeward
1.9359 of 5 stars
$0.75
+2.9%
$9.00
+1,100.0%
-80.8%$8.26M$25.66M-0.2560
TNON
Tenon Medical
1.5278 of 5 stars
$1.03
+1.0%
$4.67
+353.1%
+62.1%$7.82M$3.28M-0.048
SINT
Sintx Technologies
2.9769 of 5 stars
$2.97
-10.8%
$28.00
+842.8%
-45.7%$7.46M$2.89M-0.0640Positive News
Gap Down
High Trading Volume
POAI
Predictive Oncology
2.7218 of 5 stars
$0.80
+1.3%
$3.00
+275.0%
-27.5%$7.14M$1.62M-0.2630
LUCY
Innovative Eyewear
0.1238 of 5 stars
$2.15
+1.4%
N/A-62.0%$6.66M$1.71M-0.549News Coverage
STRR
Star Equity
3.5045 of 5 stars
$1.96
-2.0%
$5.00
+155.1%
-57.0%$6.29M$57.17M-0.57460Positive News
ICU
SeaStar Medical
0.421 of 5 stars
$0.56
-5.3%
N/A-90.4%$6.27M$428K-0.162
STSS
Sharps Technology
0.9895 of 5 stars
$5.87
+2.4%
N/AN/A$5.98MN/A0.003

Related Companies and Tools


This page (NASDAQ:BJDX) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners